RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome
Clinical trial NCT03970577 · UNKNOWN
Trial details
- NCT number
- NCT03970577
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2023-11-29
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.